Specialty Pharmaceutical Pipeline 2024
Pricing: Free for Members and $30 for Non-Members
Course Description
As the specialty pharmaceutical pipeline continues to erupt, it is important to stay up-to-date on key late Phase 3 products, as well as those with pending approval dates over the next year. This pipeline session will focus on new and emerging specialty medications and their projected time to market, any potential FDA or legal delays, their potential place in therapy, and implications for managed care pharmacy.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Identify high-impact specialty and biosimilar drugs that are recently approved or likely to emerge from the pharmaceutical pipeline in the next 12 months.
- Describe the mechanism of action and expected indications of promising agents in the pipeline.
- Outline key Pharmacy and Therapeutics Committee considerations and cost impacts of specialty pipeline products.
- Discuss FDA, legal, or current events that may impact important pipeline drug release dates or sales.
Faculty
Jeffrey Casberg, MS, RPh
Sr. VP of Pharmacy
IPD Analytics, LLC
Old Saybrook, CT
Leslie Fish, RPh, PharmD
SVP of Pharmacy
IPD Analytics, LLC
Worcester, MA
Moderator
Carly Rodriguez, PharmD, FAMCP
Vice President & Chief Pharmacy Officer
Moda Health
Portland, OR
Financial Relationship Disclosures
Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
Jeffrey Casberg Faculty | Disclosed no relevant financial relationships. |
Leslie Fish Faculty | Disclosed no relevant financial relationships. |
Kimberly Lenz Reviewer | Disclosed no relevant financial relationships. |
Brittany Henry Planner | Disclosed no relevant financial relationships. |
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
Accreditation:
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN: 00233-0000-24-025-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: May 3, 2024 • Expiration Date: December 31, 2025
Activity Fee: Free for Members and $30 for Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP 2024. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.25 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 1.25 Certificate of Completion
Price
Required Hardware/software
System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities